Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Last Week’s Big Dow Losers: Merck & Co., Inc. (MRK), United Technologies Corporation (UTX), Alcoa Inc (AA)

Page 1 of 2

If you don’t religiously follow the markets and are just seeing the weekly results for the first time, it would appear that this past week was simply a slight winner and nothing more. Easily beating the other two major indexes, the Dow Jones Industrial Average ended the week up 89 points, or 0.63%. Gaining 0.25%, the Nasdaq performed slightly better than the S&P 500, which rose a more modest 0.17%.

Merck & Co., Inc. (NYSE:MRK)But in fact, the week was a real roller coaster, and it all started on Monday, when investors, fearing the outcome of the Italian elections, sent the Dow down 216 points. That was followed by two days in which the blue chip stocks rose 116 points and 175 points, respectively. By then the markets needed a little breather, and that caused Thursday to be a relatively quiet, as the Dow lost just 21 points. Then came Friday, the day the massive $85 billion in government spending cuts went into effect. Investors ended up adding 35 points after huge swings between positive and negative territory during the last trading session of the week.

But even though the Dow closed higher for the week, 11 of its components didn’t, and two were lower by more than 1%. And considering the previous week, when seven of the 10 losers were down more than 2.4%, this week wasn’t so bad.

Before we go through the Dow losers, let’s look at the index’s big winner of the week: The Home Depot, Inc. (NYSE:HD), which rose by 5.26% during the past five trading days. The biggest move higher came on Tuesday, after the company announced quarterly earnings the evening before. Earnings per share came in at $0.68 after analysts were expecting only $0.64. Revenue hit $18.25 billion while also crushing the $17.7 billion many were expecting. In Home Depot’s earnings release, management also announced a 35% increase to the dividend and plans to buy back $17 billion worth of stock.

Also on Tuesday, the Case-Shiller Home Price Index reported that home prices rose 7.3% in 2012. There are now a number of economic indicators pointing toward a strong recovery in housing, and not only are we seeing the price increase, but the number of new homes being built is also rising. Any recovery here is great news for the U.S. economy as a whole, and for Home Depot shareholders in general.

The big losers
United Technologies Corporation (NYSE:UTX)
stock declined by 0.39% over the past five trading days. The biggest hit, a 0.7% drop, came on Monday in reaction to a report from the previous Friday, which indicated that a crack was discovered in the engine of an F-35. The Pentagon then grounded all of the military’s 51 F-35’s until the cause was determined. The engines are built by United Technologies subsidiary Pratt & Whitney. The jet was cleared to continue flying on Thursday, when inspections revealed that no other planes showed signs of stress.

The F-35 is the Pentagon’s most expensive weapons program, which is probably why one crack shut down the whole fleet of planes. But if this turns out to be an isolated incident, United Technologies Corporation (NYSE:UTX) shares should rebound easily.

Shares of Merck & Co., Inc. (NYSE:MRK) fell by 0.79% this week after a study released by JAMA Internal Medicine linked pancreatitis to the use of Merck’s diabetes drug Januvia. The study showed that patients taking either Merck & Co., Inc. (NYSE:MRK)’s Januvia or Byetta, also a diabetes drug made in a joint venture between AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY), were more likely to develop pancreatitis, which also can lead to further health problems. As the number of U.S. diabetes cases continues to increase, finding a safe drug to treat the disease would help the big pharmaceutical players recoup lost revenue as blockbuster drugs continue to fall off the patent cliff.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!